Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Image

[Articles] Cardiovascular outcomes with survodutide in adults with obesity at increased cardiovascular risk (SYNCHRONIZE-CVOT): a double-blind, randomised, placebo-controlled, phase 3 trial

Journal content Created on 09 Nov 2026 The Lancet

Published in

The Lancet, The Lancet (Reed Elsevier)

Content

There is no additional content. Please click on the source link to view more information.

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 29
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement